About Stabilizer of axonemal microtubules 2
Stabilizer of axonemal microtubules 2 (SAXO2) is a protein
from Homo sapiens identified by UniProt accession
Q658L1, 398 residues long.
MolForge cross-references it against 0 known binders and
27 disease associations.
Target properties
| Protein name | Stabilizer of axonemal microtubules 2 |
| UniProt accession | Q658L1 |
| Gene | SAXO2 |
| Organism | Homo sapiens |
| Length | 398 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (27)
Diseases linked to this target (Open Targets).
- self reported educational attainment · score 0.16
- intelligence · score 0.14
- cognitive function measurement · score 0.14
- cerebellar volume measurement · score 0.14
- testosterone measurement · score 0.12
- erythrocyte count · score 0.10
- skin pigmentation · score 0.10
- creatinine measurement · score 0.10
- episodic memory · score 0.07
- schizophrenia · score 0.06
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q658L1-F1 | alphafold | PREDICTED | 70.32 | — |
Amino-acid sequence (398 residues)
MGAKSMRSWC LCQICSCGSD YCPYEIVKQP RHVPEEYKPK QGKIDLGTTY KRDLNSYKVQ PVAIVRPLER QVKKGKLDTV PTYKDDYRAW DLHKSELYKP EQTYHPPTVK FGNSTTFQDD FVPQEIKPRQ SFKPSSVVKR STAPFNGITS HRLDYIPHQL ELKFERPKEV YKPTDQRFED LTTHRCDFQG LIGETAKLCR PVHTRVTQNA LFEGSTEFRE SFQPWEIPPP EVKKVPEYVP PTGSMLLNST SHLDYVPYQA NHVVPIRPVS QKRSNNFPFQ GKSIMKEDFP AWESCRQGLI KKQQQIPNPS GKFDGLSTFR SHYVPHELIP TESCKPLNIA FKSSVPFDDV TMYSVEYTPK RQEICPASYP SPPGYIFDNT NSQGHKFFRK IIPAVKAF
Explore Stabilizer of axonemal microtubules 2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets